These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8666331)

  • 1. Hepatobiliary disposition of valproic acid and valproate glucuronide: use of a pharmacokinetic model to examine the rate-limiting steps and potential sites of drug interactions.
    Booth CL; Pollack GM; Brouwer KL
    Hepatology; 1996 Apr; 23(4):771-80. PubMed ID: 8666331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probenecid-associated alterations in valproate glucuronide hepatobiliary disposition: mechanistic assessment using mathematical modeling.
    Ward ES; Pollack GM; Brouwer KL
    J Pharmacol Exp Ther; 2001 Apr; 297(1):141-7. PubMed ID: 11259538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver.
    Booth CL; Brouwer KR; Brouwer KL
    Cancer Res; 1998 Aug; 58(16):3641-8. PubMed ID: 9721873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probenecid-associated alterations in valproic acid pharmacokinetics in rats: can in vivo disposition of valproate glucuronide be predicted from in vitro formation data?
    Ward ES; Pollack GM; Brouwer KL
    Drug Metab Dispos; 2000 Dec; 28(12):1433-9. PubMed ID: 11095580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats.
    Yamamura N; Imura K; Naganuma H; Nishimura K
    Drug Metab Dispos; 1999 Jun; 27(6):724-30. PubMed ID: 10348803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phenobarbital and p-hydroxyphenobarbital glucuronide on acetaminophen metabolites in isolated rat hepatocytes: use of a kinetic model to examine the rates of formation and egress.
    Studenberg SD; Brouwer KL
    J Pharmacokinet Biopharm; 1993 Apr; 21(2):175-94. PubMed ID: 8229679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein binding and hepatobiliary distribution of valproic acid and valproate glucuronide in rats.
    Brouwer KL; Hall ES; Pollack GM
    Biochem Pharmacol; 1993 Feb; 45(3):735-42. PubMed ID: 8442771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disposition of valpromide in rats and the isolated perfused rat liver.
    Billig H; Ziv E; Bar-On H; Bialer M
    Drug Metab Dispos; 1990; 18(2):238-44. PubMed ID: 1971580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
    Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic and metabolic influences on enterohepatic recirculation: simulations based upon the disposition of valproic acid in the rat.
    Pollack GM; Brouwer KL
    J Pharmacokinet Biopharm; 1991 Apr; 19(2):189-225. PubMed ID: 2013839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-dependent disposition of glucuronide metabolite of valproate.
    Yu HY; Shen YZ
    J Pharm Pharmacol; 2002 May; 54(5):633-9. PubMed ID: 12005358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits.
    Yokogawa K; Iwashita S; Kubota A; Sasaki Y; Ishizaki J; Kawahara M; Matsushita R; Kimura K; Ichimura F; Miyamoto K
    Pharm Res; 2001 Sep; 18(9):1320-6. PubMed ID: 11683247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired biliary excretion of acetaminophen glucuronide in the isolated perfused rat liver after acute phenobarbital treatment and in vivo phenobarbital pretreatment.
    Studenberg SD; Brouwer KL
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1022-7. PubMed ID: 1602370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats.
    Blotnik S; Bergman F; Bialer M
    Drug Metab Dispos; 1996 May; 24(5):560-4. PubMed ID: 8723737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats.
    Nakajima Y; Mizobuchi M; Nakamura M; Takagi H; Inagaki H; Kominami G; Koike M; Yamaguchi T
    Drug Metab Dispos; 2004 Dec; 32(12):1383-91. PubMed ID: 15345660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride.
    Khemawoot P; Maruyama C; Tsukada H; Noda H; Ishizaki J; Yokogawa K; Miyamoto K
    Biopharm Drug Dispos; 2007 Sep; 28(6):331-8. PubMed ID: 17617793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of beta-glucuronidase-resistant "glucuronides" of valproic acid after intrabiliary administration in the rat: intact absorption, fecal excretion and intestinal hydrolysis.
    Dickinson RG; Kluck RM; Eadie MJ; Hooper WD
    J Pharmacol Exp Ther; 1985 Apr; 233(1):214-21. PubMed ID: 3920383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between glucuronide conjugate levels and hepatotoxicity after oral administration of valproic acid.
    Lee MS; Lee YJ; Kim BJ; Shin KJ; Chung BC; Baek DJ; Jung BH
    Arch Pharm Res; 2009 Jul; 32(7):1029-35. PubMed ID: 19641884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired biliary elimination of beta-glucuronidase-resistant "glucuronides" of valproic acid after intravenous administration in the rat. Evidence for oxidative metabolism of the resistant isomers.
    Dickinson RG; Kluck RM; Wood BT; Eadie MJ; Hooper WD
    Drug Metab Dispos; 1986; 14(2):255-62. PubMed ID: 2870903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered hepatobiliary disposition of acetaminophen metabolites after phenobarbital pretreatment and renal ligation: evidence for impaired biliary excretion and a diffusional barrier.
    Brouwer KL; Jones JA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):657-64. PubMed ID: 2313593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.